Brady Cooper is the Director of Business Development at Biofidelity since May 2024, following a role as Account Executive at Pillar Biosciences Incorporated from October 2022 to May 2024. Prior experience includes serving as Sr. Business Development Manager - SE at Invitae and at ArcherDX, Inc. from July 2015 to October 2020, with responsibilities encompassing Next Generation Sequencing assays and associated technologies. Brady held a Business Development Manager position at Affymetrix, focusing on PCR and biochemical solutions, and served as a Corporate Service Consultant at EA - Quintiles, specializing in genomic service sales. Earlier roles included Service Solutions Sales Representative and Laboratory Associate positions at bioMérieux and Expression Analysis, respectively. Brady earned a BS in Biology & Pre-medical Science from Indiana Wesleyan University between 2005 and 2010.
Sign up to view 0 direct reports
Get started